Alzamend Neuro ALZN Balance Sheet (2020-2026)

NASDAQ ALZN
$1.78 -0.04 (-2.18%)
As of: Sep 30, 2026 · 11:52 AM EDT
Reported Financials

Alzamend Neuro Quarterly Balance Sheet

Periods 26 quarters
Latest Jul 2026

Alzamend Neuro reported total assets of $8.54M and total liabilities of $2.74M for the quarter ended Jul 2026, up 35.0% year over year. This balance sheet covers 26 quarters of results from Apr 2020 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026 Jul2026
Receivables - AccuredAcc. Int. Receivables
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
13.57M11.79M14.06M11.53M9.18M7.38M5.14M1.70M0.20M0.28M0.38M1.19M4.09M3.36M3.95M5.62M4.45M2.71M0.71M7.59M
Receivables - OtherOther Receivables
0.02M0.01M
Prepaid Assets
0.93M0.64M0.35M0.59M0.74M0.55M0.45M0.72M0.58M0.31M0.08M0.22M0.67M0.59M0.23M0.31M0.27M0.99M1.05M0.66M
Current Assets
14.50M12.43M14.41M12.11M10.33M8.42M5.84M2.41M0.78M0.59M0.46M1.42M4.77M3.95M4.18M5.93M4.72M3.70M1.76M8.25M
Non-Current Assets
Property, Plant & Equipment (Net)
0.10M0.10M0.09M0.09M0.08M0.21M0.20M0.19M0.18M0.25M0.24M0.23M0.43M0.40M0.37M0.34M0.31M0.29M
Non-Current Assets
0.10M0.10M0.09M0.09M0.08M0.21M0.20M0.19M0.18M0.25M0.24M0.23M0.43M0.40M0.37M0.34M0.31M0.29M
Assets
14.50M12.43M14.52M12.21M10.42M8.50M5.92M2.63M0.98M0.78M0.63M1.67M5.01M4.18M4.60M6.33M5.09M4.04M2.08M8.54M
Liabilities
Current Liabilities
Accounts Payables
1.13M0.46M1.16M1.03M0.65M2.64M2.87M2.74M3.67M3.83M2.93M2.88M1.25M0.73M0.63M0.98M0.72M1.86M1.35M2.74M
Notes Payables
0.30M
Payables
1.13M0.46M1.16M1.03M0.65M2.64M2.87M2.74M3.67M3.83M3.23M2.88M1.25M0.73M0.63M0.98M0.72M1.86M1.35M2.74M
Total Current Liabilities
1.48M0.47M1.16M1.03M1.64M2.64M2.87M3.83M
Non-Current Liabilities
Convertible Debt
0.34M
Preferred Stock Liabilities
0.48M
Other Non-Current Liabilities
0.74M
Total Non-Current Liabilities
4.30M
Total Liabilities
1.48M0.47M1.16M1.03M1.64M2.64M2.87M2.74M3.67M5.05M3.23M2.88M1.25M0.73M0.63M0.98M0.72M1.84M1.35M2.74M
Shareholder's Equity
Total Debt
0.30M
Common Equity
13.03M11.96M13.35M11.18M8.79M5.86M3.05M-0.11M-2.68M-4.26M-2.59M-1.21M3.75M3.45M3.97M5.34M4.37M2.20M0.73M5.80M
Liabilities and Shareholders Equity
14.50M12.43M14.52M12.21M10.42M8.50M5.92M2.63M0.98M0.78M0.63M1.67M5.01M4.18M4.60M6.33M5.09M4.04M2.08M8.54M
Retained Earnings
-22.75M-25.33M-29.19M-32.23M-35.34M-40.77M-44.07M-47.60M-50.51M-53.17M-54.02M-54.99M-56.41M-57.40M-58.54M-61.24M-62.24M-64.44M-67.31M-70.33M
Preferred Shares
1.00

Alzamend Neuro Balance Sheet API

Pull Alzamend Neuro's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ALZN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY